Abreu MT, Taylor KD, Lin Y-C et al (2002) Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease. Gastroenterology 123:679–688. https://doi.org/10.1053/gast.2002.35393
Agarwala V, Flannick J, Sunyaev S, Altshuler D (2013) Evaluating empirical bounds on complex disease genetic architecture. Nat Genet 45:1418–1427. https://doi.org/10.1038/NG.2804
Anderson CA, Boucher G, Lees CW et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43:246–252. https://doi.org/10.1038/NG.764
Annese V, Piepoli A, Latiano A et al (2005) HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum 48:57–64. https://doi.org/10.1007/s10350-004-0747-0
Babb De Villiers C, Kroese M, Moorthie S (2020) Understanding polygenic models, their development and the potential application of polygenic scores in healthcare. J Med Genet 57:725–732. https://doi.org/10.1136/JMEDGENET-2019-106763
Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40:955–962. https://doi.org/10.1038/NG.175
Barrett JC, Lee JC, Lees CW et al (2009) Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 41:1330–1334. https://doi.org/10.1038/NG.483
Borren NZ, Conway G, Garber JJ et al (2018) Differences in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases. J Crohn’s Colitis 12:525–531. https://doi.org/10.1093/ECCO-JCC/JJX154
Bouma G, Oudkerk Pool M, Crusius JB et al (1997) Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn’s disease (CD). Clin Exp Immunol 109:175–179. https://doi.org/10.1046/j.1365-2249.1997.4121510.x
Brant SR, Okou DT, Simpson CL et al (2017) Genome-wide association study identifies african-specific susceptibility loci in African Americans with inflammatory bowel disease. Gastroenterology 152:206-217.e2. https://doi.org/10.1053/J.GASTRO.2016.09.032
Brant SR, Picco MF, Achkar J-P et al (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 9:281–289. https://doi.org/10.1097/00054725-200309000-00001
Burton PR, Clayton DG, Cardon LR et al (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 447:661–678. https://doi.org/10.1038/NATURE05911
Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2:91–99. https://doi.org/10.1038/35052543
Cavanaugh JA, Bryce ME, Stanford PM et al (2001) International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet 68:1165–1171. https://doi.org/10.1086/320119
Chatterjee N, Wheeler B, Sampson J et al (2013) Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nature Genet 45(4):400–405. https://doi.org/10.1038/ng.2579
Chen G-B, Lee SH, Brion M-JA et al (2014) Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum Mol Genet 23:4710–4720. https://doi.org/10.1093/HMG/DDU174
Chen G-B, Lee SH, Montgomery GW et al (2017) Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method. BMC Med Genet. https://doi.org/10.1186/S12881-017-0451-2
Choi SW, Mak TS-H, O’Reilly PF (2020) Tutorial: a guide to performing polygenic risk score analyses. Nature Protoc 15(9):2759–2772. https://doi.org/10.1038/s41596-020-0353-1
Cleynen I, Boucher G, Jostins L et al (2016) Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet (london, England) 387:156–167. https://doi.org/10.1016/S0140-6736(15)00465-1
Cleynen I, González JR, Figueroa C et al (2013) Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBDchip European Project. Gut 62:1556–1565. https://doi.org/10.1136/gutjnl-2011-300777
Cleynen I, Halfvarsson J (2019) How to approach understanding complex trait genetics - inflammatory bowel disease as a model complex trait. Unit Europ Gastroenterol J 7:1426–1430. https://doi.org/10.1177/2050640619891120
Cleynen I, Vermeire S (2015) The genetic architecture of inflammatory bowel disease: past, present and future. Curr Opin Gastroenterol 31:456–463. https://doi.org/10.1097/MOG.0000000000000215
Crowley E, Warner N, Pan J et al (2020) Prevalence and clinical features of inflammatory bowel diseases associated with monogenic variants, identified by whole-exome sequencing in 1000 children at a single center. Gastroenterology 158:2208–2220. https://doi.org/10.1053/J.GASTRO.2020.02.023
Cuthbert AP, Fisher SA, Mirza MM et al (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867–874. https://doi.org/10.1053/gast.2002.32415
de Lange KM, Moutsianas L, Lee JC et al (2017) Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49:256–261. https://doi.org/10.1038/NG.3760
DeLisi LE (2016) A case for returning to multiplex families for further understanding the heritability of schizophrenia: a psychiatrist’s perspective. Mole Neuropsychiatry 2:15–19. https://doi.org/10.1159/000442820
Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (new York, NY) 314:1461–1463. https://doi.org/10.1126/SCIENCE.1135245
Ellinghaus D, Zhang H, Zeissig S et al (2013) Association between variants of PRDM1 and NDP52 and Crohn’s disease, based on exome sequencing and functional studies. Gastroenterology 145:339–347. https://doi.org/10.1053/J.GASTRO.2013.04.040
Frade-Proud’hon-Clerc S, Smol T, Frenois F et al (2019) A novel rare missense variation of the NOD2 gene: evidencesof implication in crohn’s disease. Intern J Mole Sci. https://doi.org/10.3390/IJMS20040835
Franke A, McGovern DPB, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42:1118–1125. https://doi.org/10.1038/NG.717
Freeman HJ (2014) Natural history and long-term clinical course of Crohn’s disease. World J Gastroenterol 20:31–36. https://doi.org/10.3748/WJG.V20.I1.31
Gomollón F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis 11:3–25. https://doi.org/10.1093/ECCO-JCC/JJW168
Guan Q (2019) A Comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. https://doi.org/10.1155/2019/7247238
Hampe J, Franke A, Rosenstiel P et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207–211. https://doi.org/10.1038/NG1954
Hampe J, Grebe J, Nikolaus S et al (2002) Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. Lancet 359:1661–1665. https://doi.org/10.1016/S0140-6736(02)08590-2
Hong M, Ye BD, Yang SK et al (2018) Immunochip meta-analysis of inflammatory bowel disease identifies three novel loci and four novel associations in previously reported loci. J Crohn’s Colitis 12:730–741. https://doi.org/10.1093/ECCO-JCC/JJY002
Huang H, Fang M, Jostins L et al (2017) Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547:173–178. https://doi.org/10.1038/NATURE22969
Hübenthal M, Löscher B-S, Erdmann J et al (2021) Current developments of clinical sequencing and the clinical utility of polygenic risk scores in inflammatory diseases. Front Immunol. https://doi.org/10.3389/FIMMU.2020.577677
Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603. https://doi.org/10.1038/35079107
Hugot J-P, Laurent-Puig P, Gower-Rousseaut C et al (1996) Mapping of a susceptibility locus for Crohn’s disease on chromosome. Nature 379:821
Hunt KA, Mistry V, Bockett NA et al (2013) Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 498:232–235. https://doi.org/10.1038/NATURE12170
Jezernik G, Mičetić-Turk D, Potočnik U (2020) Molecular genetic architecture of monogenic pediatric IBD differs from complex pediatric and adult IBD. J Personal Med 10:1–18. https://doi.org/10.3390/JPM10040243
Jostins L, Ripke S, Weersma RK et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119–124. https://doi.org/10.1038/NATURE11582
Khera AV, Chaffin M, Aragam KG et al (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50:1219–1224. https://doi.org/10.1038/S41588-018-0183-Z
留言 (0)